Management of CNV in Angioid Streaks by Intravitreal Use of Specific Anti-VEGF165 Aptamer (Pegaptanib Sodium): Long-Term Results

REFERENCES

• Georgalas I, Papaconstantinou D, Koutsandrea C, et al. Angioid streaks, clinical course, complications, and current therapeutic management. Ther Clin Risk Manag. 2009;5:81–89.
   PubMedGoogle Scholar
• Shields JA, Federman JL, Tomer TL, et al. Angioid streaks. I. Ophthalmoscopic variations and diagnostic problems. Br J Ophthalmol. 1975;59:257–266.
   PubMed Web of Science ®Google Scholar
• Piro PA, Scherga D, Fine S. Angioid streaks: Natural history and visual prognosis. In: Fine SL, Owens SL (Eds.). Management of Retinal Vascular and Macular Disorders, 1st Ed. Baltimore: Williams & Wilkins, 1983; pp. 136–139.
   Google Scholar
• Schmidt-Erfurth U, Pollreisz A, Mithsch C, et al. Antivascular endothelial growth factors in age-related macular degeneration. Dev Ophthalmol. 2010;46:21–38.
   Google Scholar
• Clarkson JG, Altman RD. Angioid streaks. Surv Ophthalmol. 1982;26:235–246.
   PubMed Web of Science ®Google Scholar
• Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Arch Ophthalmol. 1994;112:480–488.
   PubMedGoogle Scholar
• Lim JI, Bressler NM, Marsh MJ, et al. Laser treatment of choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol. 1993;116:414–423.
   PubMed Web of Science ®Google Scholar
• Gelisken O, Hendrikse F, Deutman AF. A long-term follow-up study of laser coagulation of neovascular membranes in angioid streaks. Am J Ophthalmol. 1988;105:299–303.
   PubMed Web of Science ®Google Scholar
• Pece A, Avanza P, Galli L, et al. Laser photocoagulation of choroidal neovascularization in angioid streaks. Retina. 1997;17:12–16.
   PubMed Web of Science ®Google Scholar
• Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials—TAP Report 1. Arch Ophthalmol. 1999;117:1329–1345.
   PubMed Web of Science ®Google Scholar
• Shaikh S, Ruby AJ, Williams GA. Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks. Am J Ophthalmol. 2003;135:1–6.
   PubMed Web of Science ®Google Scholar
• Browning AC, Chung AK, Ghanchi F, et al. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: One-year results of a prospective case series. United Kingdom PDT Users Group. Ophthalmology. 2005;112:1227–1331.
   PubMed Web of Science ®Google Scholar
• Heimann H, Gelisken F, Wachtlin J, et al. Photodynamic therapy with verteporfin for choroidal neovascularization associated with angioid streaks. Graefes Arch Clin Exp Ophthalmol. 2005;243:1115–1123.
   Web of Science ®Google Scholar
• Arias L, Pujol O, Rubio M, et al. Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks. Graefes Arch Clin Exp Ophthalmol. 2006;244:753–757.
   Web of Science ®Google Scholar
• Jurklies B, Bornfeld N, Schilling H. Photodynamic therapy using verteporfin for choroidal neovascularization associated with angioid streaks long-term effects. Ophthalmic Res. 2006;38:209–217.
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–1431.
   PubMed Web of Science ®Google Scholar
• Singerman LJ, Masonson H, Patel M, et al. Pegaptanib sodium for neovascular age-related macular degeneration: Third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial. Br J Ophthalmol. 2008;92:1606–1611.
   PubMed Web of Science ®Google Scholar
• Arevalo JF, Fromow-Guerra J, Sanchez JG, et al. Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: Results of the Pan-American Collaborative Retina Study Group at 12 months follow-up. Retina. 2008;28:1387–1394.
   PubMed Web of Science ®Google Scholar
• Lommatzsch A, Spital G, Trieschmann M, et al. Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks. Ophthalmologe. 2007;104:325–328.
   PubMed Web of Science ®Google Scholar
• Wiegand TW, Rogers AH, McCabe F, et al. Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaks. Br J Ophthalmol. 2009;93:47–51.
   PubMedGoogle Scholar
• Donati MC, Virgili G, Bini A, et al. Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: A case series. Ophthalmologica. 2009;223:24–27.
   PubMed Web of Science ®Google Scholar
• Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351:2805–2816.
   PubMed Web of Science ®Google Scholar
• Molina Guilabert I, Calvo-González C, Reche-Frutos J, et al. Intravitreal pegabtanib sodium in choroidal neovascularization secondary to angioid streaks. Acta Ophthalmol. 2009;87:581–582.
   Google Scholar